Your browser doesn't support javascript.
loading
Rivaroxaban for the treatment of cerebral venous thrombosis.
Esmaeili, Sara; Abolmaali, Meysam; Aarabi, Sobhan; Motamed, Mohammad Reza; Chaibakhsh, Samira; Joghataei, Mohammad Taghi; Mojtahed, Mohammad; Mirzaasgari, Zahra.
Affiliation
  • Esmaeili S; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
  • Abolmaali M; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Aarabi S; School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Motamed MR; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Chaibakhsh S; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
  • Joghataei MT; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Mojtahed M; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Mirzaasgari Z; Eye Research Center, The Five Senses Institute Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
BMC Neurol ; 21(1): 73, 2021 Feb 15.
Article in En | MEDLINE | ID: mdl-33588777

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Treatment Outcome / Intracranial Thrombosis / Factor Xa Inhibitors / Rivaroxaban Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Iran Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Treatment Outcome / Intracranial Thrombosis / Factor Xa Inhibitors / Rivaroxaban Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Iran Country of publication: United kingdom